Unknown

Dataset Information

0

Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.

ABSTRACT:

SUBMITTER: Smith S 

PROVIDER: S-EPMC8407188 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis.
| S-EPMC7049934 | biostudies-literature
Unknown Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis.
| S-EPMC4993024 | biostudies-literature
Unknown The Anti-Pseudomonal Peptide D-BMAP18 Is Active in Cystic Fibrosis Sputum and Displays Anti-Inflammatory In Vitro Activity.
| S-EPMC7565916 | biostudies-literature
Unknown Inhaled mannitol for cystic fibrosis.
| S-EPMC7195814 | biostudies-literature
Unknown Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients.
| S-EPMC4579023 | biostudies-literature
Unknown Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'.
| S-EPMC2783320 | biostudies-literature
Unknown High-Dose Inhaled Nitric Oxide as Adjunct Therapy in Cystic Fibrosis Targeting Burkholderia multivorans.
| S-EPMC7334765 | biostudies-literature
Unknown Inhaled Biologicals for the Treatment of Cystic Fibrosis.
| S-EPMC6751348 | biostudies-literature
Unknown The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
| S-EPMC5994662 | biostudies-literature
Unknown Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.
| S-EPMC4944396 | biostudies-literature